136 related articles for article (PubMed ID: 36097900)
21. Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report.
Cao Y; Yue Y; Zhou X; Luo J; Zeng X; Dong J; Liang X
Medicine (Baltimore); 2019 Mar; 98(9):e14654. PubMed ID: 30817587
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of unexpectedly HER2 positive breast carcinomas: An institutional experience.
LaBoy C; Siziopikou KP; Rosen L; Blanco LZ; Pincus JL
Pathol Res Pract; 2021 Jun; 222():153441. PubMed ID: 33857853
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of and neoadjuvant therapy for human epidermal growth factor receptor 2-positive classic invasive lobular carcinoma.
Huang X; Chen H; Ding Q; Robinson MK; Moseley TW; Bassett RL; Tang G; Lim B; Sahin AA
Hum Pathol; 2021 Nov; 117():51-59. PubMed ID: 34363799
[TBL] [Abstract][Full Text] [Related]
24. Primary squamous cell carcinoma of the breast with unusual basal-HER2 phenotype.
Shui R; Li A; Yang F; Zhou X; Yu B; Xu X; Yang W
Int J Clin Exp Pathol; 2014; 7(8):5203-9. PubMed ID: 25197398
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
26. Sonographic and pathological features of metaplastic squamous cell carcinoma of the breast: a case series.
Ye XJ; Chen XY; Ke ZB; Lin F; Wu YP; Yan L
BMC Surg; 2021 Oct; 21(1):374. PubMed ID: 34688286
[TBL] [Abstract][Full Text] [Related]
27. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
28. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
29. Metaplastic breast carcinoma: pathology and clinical outcome.
Bellino R; Arisio R; D'Addato F; Attini R; Durando A; Danese S; Bertone E; Grio R; Massobrio M
Anticancer Res; 2003; 23(1B):669-73. PubMed ID: 12680165
[TBL] [Abstract][Full Text] [Related]
30. HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report.
Tateishi K; Kiyoi M; Miyasaka M; Kawaji M; Nakanishi H; Furuta Y; Nishimatsu M; Takahashi Y; Nishikawa M; Nishimura Y
Case Rep Oncol; 2023; 16(1):1482-1488. PubMed ID: 38028581
[TBL] [Abstract][Full Text] [Related]
31. Negative estrogen-receptor invasive breast carcinoma: mammographic aspects, correlations with HER2/neu oncoprotein status.
Enache DE; Georgescu CV; Pătrană N
Rom J Morphol Embryol; 2012; 53(3 Suppl):755-62. PubMed ID: 23188436
[TBL] [Abstract][Full Text] [Related]
32. Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.
Sabatier R; Sabiani L; Zemmour C; Taix S; Chereau E; Gonçalves A; Jalaguier-Coudray A; Charafe-Jauffret E; Resbeut M; Extra JM; Viens P; Tallet A
Breast; 2016 Jun; 27():8-14. PubMed ID: 27212694
[TBL] [Abstract][Full Text] [Related]
33. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
34. Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison.
de Sampaio Góes FC; Oliveira DT; Dorta RG; Nishimoto IN; Landman G; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):83-6. PubMed ID: 14732774
[TBL] [Abstract][Full Text] [Related]
35. Early (<10 mm) HER2-Positive Invasive Breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free Survival.
Tot T
Ann Surg Oncol; 2015 Aug; 22(8):2532-9. PubMed ID: 25582746
[TBL] [Abstract][Full Text] [Related]
36. Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity.
Lim KH; Oh DY; Chie EK; Han W; Im SA; Kim TY; Park IA; Noh DY; Ha SW; Bang YJ
Jpn J Clin Oncol; 2010 Feb; 40(2):112-8. PubMed ID: 19887523
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological features and prognostic factors of 22 cases of primary squamous cell carcinoma of the breast].
Yanqi Z; Lina Z; Lin G
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):293-6. PubMed ID: 26462895
[TBL] [Abstract][Full Text] [Related]
38. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
[TBL] [Abstract][Full Text] [Related]
39. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
[TBL] [Abstract][Full Text] [Related]
40. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
